Systolic time intervals were measured in 27 normal newborn infants before and after administration of oral digoxin (30 ,ug/kg 
D ATA on myocardial responses of new- borns and infants to positive inotropic agents is almost nonexistent in comparison with such data in normal adults and adult patients with various cardiac diseases. Extrapolation of the results of the adult data could be hazardous since no one has proven that the neonatal heart is merely a miniature of the adult heart without specific properties of its own. The cardiac literature includes a number of articles which discuss the management of infants with congestive heart failure, and the recommended digitalis regimens appear to be derived from the authors' experiences in caring for sick babies with heart disease.1-7 Gauging response to digitalis in patients of any age is notoriously difficult and this would explain the extremely wide range of recommended digitalis dosages.
The dosage problem is potentially a serious one with some authors suggesting that highdose digitalis therapy is often necessary to control congestive heart failure in infancy, ' the case concerning treatment of congestive failure in infants.
A major reason for this lack of data related to digitalis effect in neonates may be the result of a 1962 study in which normal newborns were given digitalis to determine toxic levels of this drug.8 Deliberate use of high-dose digoxin has obvious potential dangers, and there was a death in that study. This resulted in a statement by Neill in 19657 that no more digitalis studies should be done on normal babies. Nonetheless, our study was designed and carried out because: (1) we were not trying to produce toxicity and in fact chose a dose we felt was completely safe, (2) consultation with other pediatric cardiologists met with a uniformly positive response as to the safety of this particular regimen, (3) the information to be gained was important if some of the problems associated with the treatment of sick infants, including those mentioned above, were to be resolved, and found to be a safe dose in newborns with heart disease. Therefore, one half of the smaller total dose, or 30 ,ug/kg, was-chosen for this normal study. In other terms, three-eighths of our usual total digitalizing dose was used. The 10 babies with signs of decompensation were studied after the same 30W'ug/kg and then again after the total 80 ,ug/kg dose had been
given. However, in most instances, the first dose was given intramuscularly. In these cases, this initial dose was reduced to 20 ,g/kg, since it has been a common pediatric practice to adjust parenteral digoxin by giving two-thirds the calculated oral dose. A phonocardiogram, an external axillary artery pulse tracing, and an ECG were recorded simultaneously at a paper speed of 100 mm/sec for each infant. The ejection time (ET) was measured from the onset of upstroke of the axillary pulse to the incisura of the dicrotic notch. The preejection period (PEP) was determined by subtracting the ejection time (ET) from the QS2, defined as the interval from the onset of the QRS complex to the first high-frequency component of the second heart sound ( fig. 1 ). The phonomicrophone used was a small, lightweight instrument made especially for infants* and was taped over the upper sternum. A small funnel connected by rubber tubing to a Cambridge pulse transducer was placed over the axillary artery. A six-channel Cambridge (English) photographic recorder was used. Measurements of time intervals were made to the nearest 5 msec.
Data were subjected to standard statistical analyses employing a PDP-12 digital computer. These included calculation of standard deviation and standard error of the mean, least-squares linear regression and correlation, and the Student t test for differences in paired samples. The infants with congestive heart failure received much larger doses of digoxin than the normal subjects. These babies were studied before and after receiving the same doses of digoxin as the normal infants (30 ,g/kg) and then restudied after receiving our standard "total digitalizing dose" of 80 ,g/kg. The majority showed the same shortening of PEP after the first dose as did the normal subjects, and there was no further change after the much larger dose (table 2, fig. 4 
